Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:17 AM
Ignite Modification Date:
2025-12-25 @ 2:17 AM
NCT ID:
NCT00616460
Eligibility Criteria:
Inclusion Criteria:
Inclusion criteria (any of the following):
* ≥75 years
* Creatinin clearance rate \< 60 ml per minute
* Anemia (Hb 9-11 mg%)
* Hypertension: BP \> 180/95 mmHg but less than 210/110 m Hg
* Diabetic Pts
* Steroid treated Pts
* Recent (within 6 weeks) non major surgery
* Pts with hematological disorders associated with tendency for bleeding like Thrombocytopenia (platelets 50000-150000) included TTP;
Exclusion Criteria:
Exclusion criteria:
* Age \< 18 year
* Acute STEMI (Primary PCI)\*
* Rescue angioplasty \<12h after lytic therapy\*
* Active bleeding
* S.C LMWH \< 8 hours or UFH \< 4 hours before PCI
* Using IIb /IIIa as an upstream therapy before PCI
* PCI which will be involved with obligatory IIb /IIIa therapy:
(thrombotic complication, occlusive dissection)
* INR\>1.5 on day of cathetrization
* Bolus of 600mg of Clopidogrel before PCI
* Current pregnancy or women in reproductive age without contraceptives
* Hypersensitivity to heparin or bivalirudin or its components \*(possible using IIB/IIIA)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00616460
Study Brief:
Protocol Section:
NCT00616460